Table 3.
31mer mutant oligonucleotides showing high inhibition
| Oligonucleotide | Sequence | Extended thrombin time (s) |
|---|---|---|
| L6-4 | CACTG GTA GG TT GG TGT GG TT GG AGC CAGTG | 90.9 |
| L6-7 | CACTG CTA GG TT GG TGT GG TT GG GGG CAGTG | 89.6 |
| L6-1 | CACTG GTA GG TT GG TGT GG TT GG ATC CAGTG | 87.8 |
| L6-11 | CACTG GGA GG TT GG TGT GG TT GG GGC CAGTG | 79.6 |
| L6-6 | CACTG GCG GG TT GG TGT GG TT GG GAC CAGTG | 76.1 |
| L6-5 | CACTG GTA GG TT GG TGT GG TT GG GTC CAGTG | 69.3 |
| L6-12 | CACTG GCA GG TT GG TGT GG TT GG GGC CAGTG | 63.9 |
| Prototype | GG TT GG TGT GG TT GG | 62.4 |
| L6-3 | CACTG GAT GG TT GG TGT GG TT GG GGC CAGTG | 47.8 |
| L6-2 | CACTG GTA GG TT GG TGT GG TT GG GCC CAGTG | 25.8 |
| L6-9 | CACTG GGG GG TT GG TGT GG TT GG GGC CAGTG | 25.0 |
| L6-10 | CACTG GTA GG TT GG TGT GG TT GG CGC CAGTG | 20.0 |
| L6-8 | CACTG GCC GG TT GG TGT GG TT GG GGC CAGTG | 19.0 |